From circuits to behavior: Amygdala dysfunction in fragile X syndrome

被引:1
|
作者
Svalina, Matthew N. N. [1 ,2 ,3 ,4 ]
Sullivan, Regina [5 ,6 ]
Restrepo, Diego [2 ,4 ]
Huntsman, Molly M. M. [2 ,3 ,7 ]
机构
[1] Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Neurosci Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA
[4] Univ Colorado, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO USA
[5] Nathan S Kline Inst Psychiat Res, Brain Inst, Orangeburg, NY USA
[6] NYU, Child Study Ctr, Sch Med, Child & Adolescent Psychiat, New York, NY USA
[7] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA
来源
关键词
critical period; synaptic plasticity; basolateral amygdala; fragile X syndrome; development; E/I balance; MENTAL-RETARDATION PROTEIN; CRITICAL-PERIOD PLASTICITY; MESSENGER-RNA TRANSLATION; LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; MOUSE MODEL; GABAERGIC INTERNEURONS; GABA(A) RECEPTOR; CONDITIONED FEAR; BRAIN-STEM;
D O I
10.3389/fnint.2023.1128529
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a repeat expansion mutation in the promotor region of the FMR1 gene resulting in transcriptional silencing and loss of function of fragile X messenger ribonucleoprotein 1 protein (FMRP). FMRP has a well-defined role in the early development of the brain. Thus, loss of the FMRP has well-known consequences for normal cellular and synaptic development leading to a variety of neuropsychiatric disorders including an increased prevalence of amygdala-based disorders. Despite our detailed understanding of the pathophysiology of FXS, the precise cellular and circuit-level underpinnings of amygdala-based disorders is incompletely understood. In this review, we discuss the development of the amygdala, the role of neuromodulation in the critical period plasticity, and recent advances in our understanding of how synaptic and circuit-level changes in the basolateral amygdala contribute to the behavioral manifestations seen in FXS.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome
    Kates, WR
    Abrams, MT
    Kaufmann, WE
    Breiter, SN
    Reiss, AL
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1997, 75 (01) : 31 - 48
  • [22] Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala
    Martin, Brandon S.
    Corbin, Joshua G.
    Huntsman, Molly M.
    JOURNAL OF NEUROPHYSIOLOGY, 2014, 112 (04) : 890 - 902
  • [23] Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome
    Suvrathan, Aparna
    Hoeffer, Charles A.
    Wong, Helen
    Klann, Eric
    Chattarji, Sumantra
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (25) : 11591 - 11596
  • [24] Hippocampal dysfunction and cognitive impairment in Fragile-X Syndrome
    Bostrom, Crystal
    Yau, Suk-yu
    Majaess, Namat
    Vetrici, Mariana
    Gil-Mohapel, Joana
    Christie, Brian R.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 68 : 563 - 574
  • [25] GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model
    Gatto, Cheryl L.
    Pereira, Daniel
    Broadie, Kendal
    NEUROBIOLOGY OF DISEASE, 2014, 65 : 142 - 159
  • [27] Autonomic Dysfunction in the Fragile X Associated Tremor/Ataxia Syndrome
    Lazarus, Joash
    Allen, Emily
    Shubeck, Lisa
    Sherman, Stephanie
    Juncos, Jorge
    NEUROLOGY, 2013, 80
  • [28] Correction of amygdalar dysfunction in a rat model of fragile X syndrome
    Fernandes, Giselle
    Mishra, Pradeep K.
    Nawaz, Mohammad Sarfaraz
    Donlin-Asp, Paul G.
    Rahman, Mohammed Mostafizur
    Hazra, Anupam
    Kedia, Sonal
    Kayenaat, Aiman
    Songara, Dheeraj
    Wyllie, David J. A.
    Schuman, Erin M.
    Kind, Peter C.
    Chattarji, Sumantra
    CELL REPORTS, 2021, 37 (02):
  • [29] The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome
    Cea-Del Rio, Christian A.
    Huntsman, Molly M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [30] Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
    Telias, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (41) : 4394 - 4404